Dover Advisors LLC Sells 33 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Dover Advisors LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% in the first quarter, HoldingsChannel reports. The institutional investor owned 5,962 shares of the healthcare conglomerate’s stock after selling 33 shares during the quarter. UnitedHealth Group makes up about 1.4% of Dover Advisors LLC’s holdings, making the stock its 15th biggest holding. Dover Advisors LLC’s holdings in UnitedHealth Group were worth $3,123,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter valued at $28,000. Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group during the 4th quarter valued at $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter valued at $32,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, CFO John F. Rex bought 17,175 shares of the company’s stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now owns 203,796 shares of the company’s stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer now owns 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have bought a total of 109,408 shares of company stock worth $31,607,768 over the last three months. Corporate insiders own 0.28% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently weighed in on UNH. Deutsche Bank Aktiengesellschaft dropped their price target on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a report on Wednesday, May 14th. Argus cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. Piper Sandler lowered their target price on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research note on Tuesday, June 3rd. Bank of America cut UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their target price for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, Baird R W cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $426.52.

UnitedHealth Group Stock Performance

UNH stock opened at $313.39 on Friday. The business’s 50-day moving average price is $386.66 and its two-hundred day moving average price is $474.19. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $284.28 billion, a PE ratio of 20.22, a P/E/G ratio of 1.37 and a beta of 0.45. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the company earned $6.91 EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.82%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group’s payout ratio is 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.